SCHEMBL12410184

SCHEMBL12410184

O=CCCOCCCNCCCCC1SCC2NC(=O)NC21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HLCS P50747 6/20 0.53
▸ TDP1 Q9NUW8 5/20 0.52
▸ PKM P14618 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ ABL1 P00519 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ IDE P14735 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ RIN1 Q13671 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ F2 P00734 1/20 0.44
▸ PRSS1 P07477 1/20 0.44
▸ PRSS2 P07478 1/20 0.44
▸ PRSS3 P35030 1/20 0.44
▸ TPSAB1 Q15661 1/20 0.44
▸ FOLH1 Q04609 2/20 0.44
▸ CA12 O43570 2/20 0.43
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12414007 0.88 HLCS (0.60) HLCSTDP1PKMMEN1ABL1
SCHEMBL2607879 0.84 TDP1 (0.58) HLCSTDP1PKMMEN1ABL1
SCHEMBL13225457 0.84 TDP1 (0.60) HLCSTDP1PKMMEN1ABL1
SCHEMBL2359251 0.83 HLCS (0.56) HLCSTDP1PKMMEN1ABL1
SCHEMBL15279174 0.82 F2 (0.66) TDP1PKMMEN1ABL1LMNA
SCHEMBL13498152 0.82 F2 (0.65) TDP1PKMF2PRSS1PRSS2
SCHEMBL13167087 0.82 TDP1 (0.55) HLCSTDP1PKMMEN1ABL1
SCHEMBL2359254 0.82 HLCS (0.65) HLCSTDP1PKMMEN1ABL1
SCHEMBL21509082 0.81 TDP1 (0.60) TDP1PKMMEN1ABL1LMNA
SCHEMBL23476650 0.81 HLCS (0.68) HLCSTDP1PKMMEN1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9763995-B2 Polymer conjugates of protegrin peptides NEKTAR THERAPEUTICS (US) 2017-09-19 — — US disclosed
US-20170035898-A1 CONJUGATES OF AN IL-15 MOIETY AND A POLYMER NEKTAR THERAPEUTICS 2017-02-09 — — US disclosed
US-20160158311-A1 POLYMER CONJUGATES OF PROTEGRIN PEPTIDES NEKTAR THERAPEUTICS 2016-06-09 — — US disclosed
US-20110171162-A1 POLYMER CONJUGATES OF THYMOSIN ALPHA 1 PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-14 — — US disclosed
US-20110171163-A1 POLYMER CONJUGATES OF ZICONOTIDE PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-14 — — US disclosed
US-20110165113-A1 POLYMER CONJUGATES OF V681-LIKE PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171163-A1 POLYMER CONJUGATES OF ZICONOTIDE PEPTIDES NGLY1, VIP, IAPP HLCS 2179/4885TDP1 4342/4885PKM 2782/4885
US-20160158311-A1 POLYMER CONJUGATES OF PROTEGRIN PEPTIDES PSMG3, PSMB11, UBQLN1 HLCS 1748/4885TDP1 3024/4885PKM 4283/4885
US-20110171162-A1 POLYMER CONJUGATES OF THYMOSIN ALPHA 1 PEPTIDES TMSB4X, TMSB10, TAP1 HLCS 1020/4885TDP1 901/4885PKM 4727/4885
US-20110165113-A1 POLYMER CONJUGATES OF V681-LIKE PEPTIDES NGLY1, VIP, DNPEP HLCS 1322/4885TDP1 3255/4885PKM 4290/4885
US-20170035898-A1 CONJUGATES OF AN IL-15 MOIETY AND A POLYMER IL15, IL15RA, IL2 HLCS 598/4885TDP1 4118/4885PKM 3894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback